Latest BML Capital Management, LLC Stock Portfolio
$155Million | No. of Holdings #15
BML Capital Management, LLC Performance
2026 Q1+19.38%
YTD+19.38%
2025-8.75%
About BML Capital Management, LLC and 13F Hedge Fund Stock Holdings
On 2026-05-06, the fund reported it's updated stock portfolio. In the 13F Holdings report, BML Capital Management, LLC reported an equity portfolio of $155.8 Millions as of 31 Mar, 2026. <br><br> The top stock holdings of BML Capital Management, LLC are ACRS, AVIR, ORMP. The fund has invested 34.3% of it's portfolio in ACLARIS THERAPEUTICS INC and 24.4% of portfolio in ATEA PHARMACEUTICALS INC. <br><br> The fund managers got completely rid off LISATA THERAPEUTICS INC (CLBS) stocks. They significantly reduced their stock positions in ATEA PHARMACEUTICALS INC (AVIR). BML Capital Management, LLC opened new stock positions in TILLYS INC (TLYS), KRAFT HEINZ CO (KHC) and JANUX THERAPEUTICS INC (JANX). The fund showed a lot of confidence in some stocks as they added substantially to OUTSET MED INC (OM), IMAGENEBIO INC (IKNA) and PMV PHARMACEUTICALS INC (PMVP).
BML Capital Management, LLC Equity Portfolio Value
Last Reported on: 06 May, 2026
$155Million
as of May 06, 2026BML Capital Management, LLC Annual Return Estimates Vs S&P 500
Our best estimate is that BML Capital Management, LLC made a return of 19.38% in the last quarter. In trailing 12 months, it's portfolio return was 39.45%.
- Performance
- S&P 500
New Buys
| Ticker | $ Bought |
|---|---|
| tillys inc | 8,707,500 |
| kraft heinz co | 2,811,250 |
| janux therapeutics inc | 2,153,960 |
New stocks bought by BML Capital Management, LLC
Additions
| Ticker | % Inc. |
|---|---|
| outset med inc | 250 |
| imagenebio inc | 13.39 |
| pmv pharmaceuticals inc | 0.53 |
Additions to existing portfolio by BML Capital Management, LLC
Reductions
| Ticker | % Reduced |
|---|---|
| atea pharmaceuticals inc | -5.76 |
BML Capital Management, LLC reduced stake in above stock
Sold off
| Ticker | $ Sold |
|---|---|
| lisata therapeutics inc | -136,427 |
BML Capital Management, LLC got rid off the above stocks
Sector Distribution
BML Capital Management, LLC has about 84.8% of it's holdings in Healthcare sector.
- Healthcare
- Consumer Cyclical
- Consumer Defensive
| Sector | % |
|---|---|
| Healthcare | 84.8 |
| Consumer Cyclical | 9.7 |
| Consumer Defensive | 4.7 |
Market Cap. Distribution
BML Capital Management, LLC has about 4.7% of it's portfolio invested in the large-cap and mega-cap stocks.
- SMALL-CAP
- MICRO-CAP
- NANO-CAP
- LARGE-CAP
- MID-CAP
| Category | % |
|---|---|
| SMALL-CAP | 60.2 |
| MICRO-CAP | 21.2 |
| NANO-CAP | 9 |
| LARGE-CAP | 4.7 |
| MID-CAP | 4.1 |
Stocks belong to which Index?
About 89% of the stocks held by BML Capital Management, LLC either belong to S&P 500 or RUSSELL 2000 index.
- RUSSELL 2000
- Others
- S&P 500
| Index | % |
|---|---|
| RUSSELL 2000 | 80.1 |
| Others | 11 |
| S&P 500 | 8.9 |
BML Capital Management, LLC Holdings Map
This heatmap illustrates the top 50 positions within the fund's portfolio.
Current Stock Holdings of BML Capital Management, LLC
BML Capital Management, LLC has 15 stocks in it's portfolio. About 94% of the portfolio is in top 10 stocks. TIL proved to be the most loss making stock for the portfolio. AVIR was the most profitable stock for BML Capital Management, LLC last quarter.
$155.44MTotal Value
16.00Positions
06 May, 2026Last Reported
| Expand | Holdingsorted ascending | % Portfolio | Shares Held | $ Value | % Change |
|---|---|---|---|---|---|
 Aclaris Therapeutics Inc BML Capital Management, LLC's holding in Aclaris Therapeutics Inc over time | 34.31% | 14,250,000 | $53.44M 34.31% | 0%unchanged 0 percentunchanged | |
 Atea Pharmaceuticals Inc BML Capital Management, LLC's holding in Atea Pharmaceuticals Inc over time | 24.38% | 7,058,660 | $37.98M 24.38% | 5.76%decreased 5.76 percentreduced | |
 Lisata Therapeutics Inc BML Capital Management, LLC's holding in Lisata Therapeutics Inc over time | 0% | 0.00 | $0.00 0% | 100%decreased 100 percentsold off | |
 Imagenebio Inc Imagenebio IncIKNA BML Capital Management, LLC's holding in Imagenebio Inc over time | 0.64% | 200,730 | $1.00M 0.64% | 13.39%increased 13.39 percentadded | |
 Janux Therapeutics Inc BML Capital Management, LLC's holding in Janux Therapeutics Inc over time | 1.38% | 154,961 | $2.15M 1.38% | Newnew position | |
 Kraft Heinz Co BML Capital Management, LLC's holding in Kraft Heinz Co over time | 1.8% | 125,000 | $2.81M 1.8% | Newnew position | |
 Carmax Inc Carmax IncKMX BML Capital Management, LLC's holding in Carmax Inc over time | 4.14% | 155,000 | $6.44M 4.14% | 0%unchanged 0 percentunchanged | |
 Kezar Life Sciences Inc BML Capital Management, LLC's holding in Kezar Life Sciences Inc over time | 3.43% | 720,787 | $5.35M 3.43% | 0%unchanged 0 percentunchanged | |
 Outset Med Inc BML Capital Management, LLC's holding in Outset Med Inc over time | 4.69% | 1,902,200 | $7.30M 4.69% | 250.2%increased 250.2 percentadded | |
 Oramed Pharmaceuticals Inc BML Capital Management, LLC's holding in Oramed Pharmaceuticals Inc over time | 6.91% | 3,167,230 | $10.77M 6.91% | 0%unchanged 0 percentunchanged | |
 Pliant Therapeutics Inc BML Capital Management, LLC's holding in Pliant Therapeutics Inc over time | 1.25% | 1,546,140 | $1.95M 1.25% | 0%unchanged 0 percentunchanged | |
 Pmv Pharmaceuticals Inc BML Capital Management, LLC's holding in Pmv Pharmaceuticals Inc over time | 4.24% | 5,320,000 | $6.60M 4.24% | 0.53%increased 0.53 percentadded | |
 Target Corp Target CorpTGT BML Capital Management, LLC's holding in Target Corp over time | 2.92% | 37,500 | $4.54M 2.92% | 0%unchanged 0 percentunchanged | |
 Instil Bio Inc BML Capital Management, LLC's holding in Instil Bio Inc over time | 3.42% | 645,600 | $5.32M 3.42% | 0%unchanged 0 percentunchanged | |
 Tillys Inc Tillys IncTLYS BML Capital Management, LLC's holding in Tillys Inc over time | 5.59% | 2,150,000 | $8.71M 5.59% | Newnew position | |
Shs Connect Biopharma Hldgs LtdConnect Biopharma Hldgs Ltd | 0.69% | 408,887 | $1.07M 0.69% | 0%unchanged 0 percentunchanged | |